Home
Latest Filings
Latest Buys
Latest Sells
Institutions
Derivatives
Hot Buys
Data Screener
Email Alerts
Insider Charts
SWM
- As of 05/21/24, 03:30:40 AM: 21 Insider Transactions.
Sector:
Consumer Goods
Industry:
Paper & Paper Products
Prev Close:
$36.15
Avg Vol(3m):
170,346
P/E:
12.00
EPS:
3.01
Email this page to a friend.
Insider Transactions for SWM
Buy/Sell*
Filed Date
Subject
Symbol
Acquirer
Pct Owned
Details
S
2020-02-14 11:07:35.0
Revance Therapeutics
RVNC
WELLINGTON MANAGEMENT GROUP LLP
5.68%
view
S
2020-03-13 16:22:55.0
Revance Therapeutics
RVNC
GIC Private Ltd
7.2%
view
S
2020-02-05 15:17:54.0
Revance Therapeutics
RVNC
FRANKLIN RESOURCES INC
6.7%
view
B
2020-01-08 15:11:05.0
Revance Therapeutics
RVNC
WELLINGTON MANAGEMENT GROUP LLP
11.44%
view
S
2019-08-12 16:09:31.0
Revance Therapeutics
RVNC
Bank of New York Mellon Corp
4.81%
view
S
2019-02-14 07:53:43.0
Revance Therapeutics
RVNC
Essex Woodlands Health Ventures VIII
4.2%
view
B
2019-02-12 10:00:55.0
Revance Therapeutics
RVNC
WELLINGTON MANAGEMENT GROUP LLP
8.7%
view
S
2019-01-29 13:56:12.0
Revance Therapeutics
RVNC
FRANKLIN RESOURCES INC
8.0%
view
B
2019-01-04 09:29:11.0
Revance Therapeutics
RVNC
WELLINGTON MANAGEMENT GROUP LLP
10.38%
view
S
2018-04-09 17:28:57.0
Revance Therapeutics
RVNC
ArrowMark Colorado Holdings LLC
4.8%
view
S
2018-02-08 12:09:49.0
Revance Therapeutics
RVNC
WELLINGTON MANAGEMENT GROUP LLP
9.5%
view
S
2018-02-07 15:02:00.0
Revance Therapeutics
RVNC
Bank of New York Mellon Corp
5.9%
view
B
2018-01-23 17:08:53.0
Revance Therapeutics
RVNC
BlackRock Inc
7.1%
view
S
2017-02-09 13:19:19.0
Revance Therapeutics
RVNC
NovaQuest Pharma Opportunities Fund III
10.9%
view
B
2017-02-03 12:50:47.0
Revance Therapeutics
RVNC
BlackRock Inc
7.1%
view
B
2017-01-11 12:49:32.0
Revance Therapeutics
RVNC
Essex Woodlands Health Ventures VIII
16.4%
view
S
2016-02-10 13:40:28.0
Revance Therapeutics
RVNC
FRANKLIN RESOURCES INC
11.1%
view
B
2016-01-28 15:59:50.0
Revance Therapeutics
RVNC
Bank of New York Mellon Corp
7.16%
view
B
2016-01-21 16:54:02.0
Revance Therapeutics
RVNC
JPMORGAN CHASE & CO
10.4%
view
S
2015-02-17 07:53:29.0
Revance Therapeutics
RVNC
Visium Asset Management
4.2%
view
B
2015-01-09 13:09:19.0
Revance Therapeutics
n/a
Visium Asset Management
6.1%
view
* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.